Hara Akemi, Ozaki Akihiko, Murakami Michio, Saito Hiroaki, Nashimoto Mika, Hori Daisuke, Tsubokura Masaharu, Gonda Kenji, Wada Masahiro, Tachibana Kazunoshin, Ohtake Tohru, Tabuchi Takahiro
Medical Governance Research Institute, Minato City 108-0074, Japan.
Center for Infectious Disease Education and Research, The University of Osaka, Suita City 565-0871, Japan.
Cancers (Basel). 2025 Apr 23;17(9):1411. doi: 10.3390/cancers17091411.
: While health disparities affecting sexual minority women are well-documented globally, little is known about cancer screening behaviors among sexual minority women in Japan. Following our previous study on breast cancer screening, this study examined cervical cancer screening participation patterns and compared screening behaviors between both cancer types among sexual minority women in Japan. : We analyzed data from 13,730 individuals with female sex assigned at birth who participated in a nationwide online survey between September and November 2023. Multinomial logistic regression was used to examine factors associated with screening participation, comparing sexual minority women (n = 2685) and women who are not part of a sexual minority (n = 11,045). Among participants aged 40 and above (n = 8933), we compared participation patterns between cervical and breast cancer screenings. : Sexual minority women showed significantly lower cervical cancer screening rates compared to women who are not part of a sexual minority (38.7% vs. 45.6%, < 0.001), with a wider disparity than observed in breast cancer screening (43.4% vs. 45.9%, < 0.001). Among those aged 40 and above, sexual minority women were more likely to skip both screenings (35.0% vs. 27.2%) and less likely to participate in both (55.0% vs. 62.6%). Additionally, our analysis revealed that participants with a current mental disorder (i.e., those reporting ongoing mental health issues) were more likely to intend to undergo cervical cancer screening (aOR = 1.39, 95% CI = 1.15-1.67, = 0.001). In contrast, among bisexual participants and those classified as having "other" mental health conditions-defined as a history of mental health issues without current symptoms-exhibited significantly lower odds of being screened (aOR = 0.31, 95% CI = 0.11-0.82, = 0.02). : Significant disparities exist in cancer screening participation among sexual minority women in Japan, with more pronounced differences in cervical cancer screening compared to breast cancer screening. These findings highlight the need for targeted interventions addressing the unique barriers to gynecological care among sexual minority women.
虽然全球范围内影响性少数群体女性的健康差异已有充分记录,但对于日本性少数群体女性的癌症筛查行为却知之甚少。继我们之前关于乳腺癌筛查的研究之后,本研究调查了宫颈癌筛查的参与模式,并比较了日本性少数群体女性中这两种癌症类型的筛查行为。
我们分析了2023年9月至11月期间参加全国在线调查的13730名出生时被指定为女性的个体的数据。使用多项逻辑回归来研究与筛查参与相关的因素,比较性少数群体女性(n = 2685)和非性少数群体女性(n = 11045)。在40岁及以上的参与者(n = 8933)中,我们比较了宫颈癌和乳腺癌筛查的参与模式。
与非性少数群体女性相比,性少数群体女性的宫颈癌筛查率显著较低(38.7% 对45.6%, < 0.001),差异比乳腺癌筛查中观察到的更大(43.4% 对45.9%, < 0.001)。在40岁及以上的人群中,性少数群体女性更有可能两项筛查都不参加(35.0% 对27.2%),而两项筛查都参加的可能性较小(55.0% 对62.6%)。此外,我们的分析显示,目前患有精神障碍的参与者(即那些报告有持续心理健康问题的人)更有可能打算接受宫颈癌筛查(调整后比值比 = 1.39,95% 置信区间 = 1.15 - 1.67, = 0.001)。相比之下,在双性恋参与者和被归类为患有“其他”心理健康状况(定义为有心理健康问题病史但目前无症状)的人群中,接受筛查的几率显著较低(调整后比值比 = 0.31,95% 置信区间 = 0.11 - 0.82, = 0.02)。
日本性少数群体女性在癌症筛查参与方面存在显著差异,与乳腺癌筛查相比,宫颈癌筛查的差异更为明显。这些发现凸显了有针对性地采取干预措施以解决性少数群体女性在妇科护理方面独特障碍的必要性。